Dina L. Masi - 20 Sep 2023 Form 4 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Role
Chief Financial Officer
Signature
/s/ Dina L Masi
Issuer symbol
INBP
Transactions as of
20 Sep 2023
Net transactions value
$0
Form type
4
Filing time
21 Sep 2023, 10:51:42 UTC
Previous filing
10 Nov 2022
Next filing
29 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INBP Common Stock Award $4,500 +50,000 +51% $0.0900* 147,200 20 Sep 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBP Stock Option (right to buy) Disposed to Issuer $4,500 -50,000 -8% $0.0900* 576,667 20 Sep 2023 Common Stock 50,000 $0.0900 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015.
F2 50,000 stock options disposed of upon exercise of the portion of a stock option grant dated June 2, 2015. 200,000 stock options for the right to purchase common stock at $0.09 remain available to exercise.